Your browser doesn't support javascript.
loading
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer.
Oddo, Daniele; Sennott, Erin M; Barault, Ludovic; Valtorta, Emanuele; Arena, Sabrina; Cassingena, Andrea; Filiciotto, Genny; Marzolla, Giulia; Elez, Elena; van Geel, Robin M J M; Bartolini, Alice; Crisafulli, Giovanni; Boscaro, Valentina; Godfrey, Jason T; Buscarino, Michela; Cancelliere, Carlotta; Linnebacher, Michael; Corti, Giorgio; Truini, Mauro; Siravegna, Giulia; Grasselli, Julieta; Gallicchio, Margherita; Bernards, René; Schellens, Jan H M; Tabernero, Josep; Engelman, Jeffrey A; Sartore-Bianchi, Andrea; Bardelli, Alberto; Siena, Salvatore; Corcoran, Ryan B; Di Nicolantonio, Federica.
Afiliación
  • Oddo D; Department of Oncology, University of Torino, Candiolo, Torino, Italy. Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Torino, Italy.
  • Sennott EM; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Barault L; Department of Oncology, University of Torino, Candiolo, Torino, Italy. Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Torino, Italy.
  • Valtorta E; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Arena S; Department of Oncology, University of Torino, Candiolo, Torino, Italy. Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Torino, Italy.
  • Cassingena A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Filiciotto G; Department of Oncology, University of Torino, Candiolo, Torino, Italy. Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Torino, Italy.
  • Marzolla G; Department of Oncology, University of Torino, Candiolo, Torino, Italy. Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Torino, Italy.
  • Elez E; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • van Geel RM; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Bartolini A; Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Torino, Italy.
  • Crisafulli G; Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Torino, Italy.
  • Boscaro V; Department of Drug Science and Technology, University of Turin, Turin, Italy.
  • Godfrey JT; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Buscarino M; Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Torino, Italy.
  • Cancelliere C; Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Torino, Italy.
  • Linnebacher M; Department of General Surgery, Division of Molecular Oncology and Immunotherapy, University of Rostock, Rostock, Germany.
  • Corti G; Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Torino, Italy.
  • Truini M; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Siravegna G; Department of Oncology, University of Torino, Candiolo, Torino, Italy. Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Torino, Italy. FIRC Institute of Molecular Oncology (IFOM), Milan, Italy.
  • Grasselli J; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Gallicchio M; Department of Drug Science and Technology, University of Turin, Turin, Italy.
  • Bernards R; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Schellens JH; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Engelman JA; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Sartore-Bianchi A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Bardelli A; Department of Oncology, University of Torino, Candiolo, Torino, Italy. Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Torino, Italy.
  • Siena S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy. Department of Oncology, Università degli Studi di Milano, Milan, Italy.
  • Corcoran RB; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Di Nicolantonio F; Department of Oncology, University of Torino, Candiolo, Torino, Italy. Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Torino, Italy. federica.dinicolantonio@unito.it.
Cancer Res ; 76(15): 4504-15, 2016 08 01.
Article en En | MEDLINE | ID: mdl-27312529
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Dosificación de Gen / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas B-raf Límite: Humans Idioma: En Revista: Cancer Res Año: 2016 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Dosificación de Gen / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas B-raf Límite: Humans Idioma: En Revista: Cancer Res Año: 2016 Tipo del documento: Article País de afiliación: Italia